A nurse and a female physician walking down a hospital corridor

Hospital Krankenhaus

Strategic Hospital Market Report - the comprehensive, data-driven introduction to the inpatient market

Insight Health supports pharmaceutical companies with the Strategic Hospital Market Report, enabling them to gain an initial, in-depth understanding of the inpatient market for a selected indication. The analyses are conducted from three complementary perspectives:

Market view: Quantification of market size and indication volume based on real inpatient data, supplemented by demographic structural features and an indication-specific forecast.
Patient journey: Description of treatment pathways and therapy decisions in clinical practice, including procedures, medicinal product use, comorbidity profiles, and length of stay.
Care in transition: Analysis of the impact of hospital reform—particularly minimum standby capacities and service groups—on the spatial and structural care landscape.

By combining these three perspectives, care structures, patient cohorts, and dynamic market changes can be consistently classified and leveraged for strategic decision-making. The report provides a unique, indication-specific insight into the inpatient market.

You will receive answers to the following questions

How will the market size for the indication develop through 2040?
Which patient age profile is particularly affected, and how will this evolve considering demographic trends?
Is the indication population growing due to diagnosis and therapy dynamics, or simply because of aging?
What impact will the hospital reform have on the care landscape?

Benefits of the strategic market report

Concise, authoritative overview of inpatient care trends
Supports answering key entry questions for market strategy and orientation
- Identification of future-proof facilities within indications/ therapies with growth potential, considering the latest market developments
- Solid foundation for targeting and key account management planning
- Precise definition of the relevant patient population as groundwork for deeper patient studies and real-world insights projects

Initial insights using the example of indication C18 (colon carcinoma)

These insights demonstrate how inpatient care for colon cancer and underlying patient structures will evolve through 2040 — and what implications this holds for the pharmaceutical industry.

You receive a well-defined set of analyses that can be used as a “building block kit” for strategic planning. Forecasts, age profiles, aspects of care, and reform effects for colon carcinoma are all provided in a compact, curated report.

The report is not limited to this indication; it is available for any indication from the ICD catalog.